Management of Mucormycosis in Uncontrolled Diabetes Mellitus

Immediate First-Line Actions

The American College of Physicians and the Infectious Diseases Society of America recommend immediately initiating liposomal amphotericin B at 5-10 mg/kg/day from day one, while simultaneously arranging urgent surgical debridement and aggressively correcting hyperglycemia and ketoacidosis, as this triple approach is mandatory for survival in patients with mucormycosis and uncontrolled diabetes mellitus 1, 2
The European Society of Clinical Microbiology and Infectious Diseases suggests starting liposomal amphotericin B at a minimum of 5 mg/kg/day immediately without test dosing or gradual escalation, as delaying treatment beyond 6 days from symptom onset doubles mortality 1, 3, 4
For CNS involvement, the guideline recommends escalating to 10 mg/kg/day 1, 3

The Infectious Diseases Society of America recommends arranging urgent surgical consultation for debridement with clean margins, as surgery reduces mortality from 62% to 11% in pulmonary disease and is equally critical for rhinocerebral involvement 5, 1, 4
Surgery serves three purposes: disease control, obtaining tissue for histopathology, and microbiological culture 1, 4

The American Diabetes Association and the European Association for the Study of Diabetes recommend aggressively correcting hyperglycemia and ketoacidosis immediately, as this is as important as antifungal therapy for survival in diabetic patients with mucormycosis 2, 1
Achieving tight glycemic control and maintaining it throughout treatment is crucial 1

The Clinical and Laboratory Standards Institute recommends obtaining tissue specimens for direct microscopy, histopathology, and culture, and performing CT or MRI imaging to determine the extent of disease 2, 1
Identifying the pathogen to the species level using molecular methods when possible is also recommended 2

The Infectious Diseases Society of America suggests continuing antifungal therapy until three endpoints are met: complete clinical resolution, complete radiological resolution on imaging, and permanent reversal of predisposing factors (sustained glycemic control) 2, 1
Monitoring serum creatinine, potassium, magnesium, and calcium during amphotericin B therapy is necessary 1

Delaying treatment initiation, as mortality increases two-fold when treatment is deferred 6 or more days from symptom onset, is a critical pitfall to avoid 5, 4
Using slow dose escalation of amphotericin B instead of giving the full dose from day one, and inadequate surgical debridement or failing to pursue surgery when anatomically feasible, are also critical pitfalls to avoid 3, 5, 1
Failing to aggressively control diabetes, as metabolic control is as critical as antifungal therapy in diabetic patients, is another critical pitfall to avoid 2, 6, 1

The overall mortality ranges from 24-49% despite optimal treatment, according to the Infectious Diseases Society of America 1
Survival is significantly better with liposomal amphotericin B (67%) versus conventional amphotericin B (39%), as reported by the American College of Physicians and the Infectious Diseases Society of America 1
Disseminated disease or CNS involvement carries mortality exceeding 80% even with optimal therapy, according to the European Society of Clinical Microbiology and Infectious Diseases 4